<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Infectious Disorders - Drug Targets</journal-id><journal-title-group><journal-title xml:lang="en">Infectious Disorders - Drug Targets</journal-title><trans-title-group xml:lang="ru"><trans-title>Infectious Disorders - Drug Targets</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1871-5265</issn><issn publication-format="electronic">2212-3989</issn><publisher><publisher-name xml:lang="en">Bentham Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">645757</article-id><article-id pub-id-type="doi">10.2174/0118715265296986240329060452</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Medicine</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Patient-Centric Approaches: Revolutionizing Rare Disease Drug Research</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Verma</surname><given-names>Abhishek</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Awasthi</surname><given-names>Ankit</given-names></name><email>info@benthamscience.net</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution>Department of Pharmaceutics, ISF College of Pharmacy</institution></aff><pub-date date-type="pub" iso-8601-date="2024-08-01" publication-format="electronic"><day>01</day><month>08</month><year>2024</year></pub-date><volume>24</volume><issue>8</issue><issue-title xml:lang="ru"/><history><date date-type="received" iso-8601-date="2025-01-11"><day>11</day><month>01</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Bentham Science Publishers</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Bentham Science Publishers</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://journals.eco-vector.com/1871-5265/article/view/645757">https://journals.eco-vector.com/1871-5265/article/view/645757</self-uri><abstract xml:lang="en"><p/></abstract><kwd-group xml:lang="en"><kwd>Rare diseases</kwd><kwd>patient-centric approaches</kwd><kwd>drug development</kwd><kwd>Patient-Reported Outcome Measures (PROMs)</kwd><kwd>precision medicine</kwd><kwd>genomics.</kwd></kwd-group></article-meta></front><body></body><back><ref-list/></back></article>
